naltrexone and interleukin-8

naltrexone has been researched along with interleukin-8 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chawda, RP; Mahajan, SD; Nair, MP; Schwartz, SA; Shanahan, TC1
Buck, J; Loeb, J; Neudeck, BL1
de Lima, A; Fuhler, GM; Lie, MRKL; Peppelenbosch, MP; van der Ent, C; van der Giessen, J; van der Woude, CJ1

Trials

1 trial(s) available for naltrexone and interleukin-8

ArticleYear
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.
    Journal of translational medicine, 2018, 03-09, Volume: 16, Issue:1

    Topics: Adult; Cell Line, Tumor; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoscopy; Epithelial Cells; Female; Humans; Inflammation; Inflammatory Bowel Diseases; Interleukin-8; Intestinal Mucosa; Male; Middle Aged; Naltrexone; Remission Induction; Wound Healing

2018

Other Studies

2 other study(ies) available for naltrexone and interleukin-8

ArticleYear
Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor.
    Journal of immunology (Baltimore, Md. : 1950), 2002, Oct-01, Volume: 169, Issue:7

    Topics: Adjuvants, Immunologic; Astrocytes; Astrocytoma; Cells, Cultured; Chemokine CCL4; Chemokines, CC; Chemokines, CXC; Down-Regulation; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunophenotyping; Interleukin-8; Macrophage Inflammatory Proteins; Morphine; Naltrexone; Receptors, CCR3; Receptors, CCR5; Receptors, Chemokine; Receptors, Interleukin-8B; Receptors, Opioid, mu; Tumor Cells, Cultured; Up-Regulation

2002
Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion.
    European journal of pharmacology, 2003, Apr-25, Volume: 467, Issue:1-3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adjuvants, Immunologic; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Interleukin-1; Interleukin-8; Naltrexone; Receptors, Opioid, kappa; Reverse Transcriptase Polymerase Chain Reaction

2003